IL22 and autoimmune polyendocrine syndrome type 1: Thus, using the condition of positivity for at least two of three autoantibodies (IFN-ω, IFN-α-2a, and IL-22), the diagnostic specificity and sensitivity of the microarray-based assay for APS-1 were 99.5% and 100%, respectively.